Investor Relations

News Release Details

<< Back

Metabolix to Conduct a Webcast of Its First Quarter 2008 Earnings Call

Apr 29, 2008

CAMBRIDGE, Mass., Apr 29, 2008 (BUSINESS WIRE) -- Metabolix, Inc. (NASDAQ: MBLX), a bioscience company focused on developing clean, sustainable solutions for plastics, chemicals and energy, announced today that it will be releasing its first quarter 2008 financial results after the market close on Wednesday, May 7, 2008. The full text of the release will also be available on the Company's website at www.metabolix.com.

Richard Eno, the Company's President and CEO will host a conference call on the same day at 4:30 p.m. (Eastern). The conference call will be webcast and can be accessed from the Company's website at www.metabolix.com in the investor relations section.

To listen to a telephonic replay of the conference call, dial toll-free 1-888-203-1112 or 1-719-457-0820 for international callers and enter passcode 4878903. The replay will be available beginning at 7:30 p.m. (Eastern) on Wednesday, May 7, 2008 and will last through 11:59 PM (Eastern) May 14, 2008. In addition, the webcast will be archived on the Company's website in the investor relations section.

About Metabolix

Founded in 1992, Metabolix, Inc. is an innovation driven bioscience company focused on providing sustainable solutions for the world's needs for plastics, chemicals and energy. The Company is taking a systems approach, from gene to end product, integrating sophisticated biotechnology with advanced industrial practice. Metabolix is now developing and commercializing Mirel(TM) bioplastics, a sustainable and biodegradable alternative to petroleum based plastics. Mirel is suitable for injection molding, cast and blown film, sheet, extrusion coating, and thermoforming. Metabolix is also developing a proprietary platform technology for co-producing plastics, chemicals and energy from crops such as switchgrass, oilseeds and sugarcane.

For more information, please visit www.metabolix.com.

(MBLX-E)

SOURCE: Metabolix, Inc.

ICR
Investor Relations:
Kathleen Heaney, 203-803-3585
ir@metabolix.com

Copyright Business Wire 2008

News Provided by COMTEX